Incremental cost-effectiveness ratio (ICER) point estimates for swabs and DBS as part of enhanced trachoma prevalence surveys in Tanzania and Mozambique, compared with grading-only costs (2022 USD).

This table shows point estimates for incremental cost, additional instances of trachoma indicators identified, and incremental cost-effectiveness ratios for the three evaluation methods in Tanzania and Mozambique. Values were calculated according to Equations 1–3 described in methods.